119 related articles for article (PubMed ID: 29411884)
1. Blastic plasmacytoid dendritic cell neoplasm with unusual morphology, MYC rearrangement and TET2 and DNMT3A mutations.
Kurt H; Khoury JD; Medeiros LJ; Huh YO
Br J Haematol; 2018 May; 181(3):305. PubMed ID: 29411884
[No Abstract] [Full Text] [Related]
2. Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm.
Kubota S; Tokunaga K; Umezu T; Yokomizo-Nakano T; Sun Y; Oshima M; Tan KT; Yang H; Kanai A; Iwanaga E; Asou N; Maeda T; Nakagata N; Iwama A; Ohyashiki K; Osato M; Sashida G
Nat Commun; 2019 Apr; 10(1):1653. PubMed ID: 30971697
[TBL] [Abstract][Full Text] [Related]
3. Mutations in TET2 and DNMT3A genes are associated with changes in global and gene-specific methylation in acute myeloid leukemia.
Ponciano-Gómez A; Martínez-Tovar A; Vela-Ojeda J; Olarte-Carrillo I; Centeno-Cruz F; Garrido E
Tumour Biol; 2017 Oct; 39(10):1010428317732181. PubMed ID: 28992762
[TBL] [Abstract][Full Text] [Related]
4. Role of DNMT3A, TET2, and IDH1/2 mutations in pre-leukemic stem cells in acute myeloid leukemia.
Chan SM; Majeti R
Int J Hematol; 2013 Dec; 98(6):648-57. PubMed ID: 23949914
[TBL] [Abstract][Full Text] [Related]
5. Rethinking the gold standard for recurrent DNA mutations detection in acute myeloid leukemia.
Novaretti MC
Eur J Haematol; 2016 Feb; 96(2):109-10. PubMed ID: 26110968
[No Abstract] [Full Text] [Related]
6. Acute myeloid leukemia with MYC rearrangement and JAK2 V617F mutation.
Ohanian M; Bueso-Ramos C; Ok CY; Lin P; Patel K; Alattar ML; Khoury JD; Rozovski U; Estrov Z; Huh YO; Cortes J; Abruzzo LV
Cancer Genet; 2015 Nov; 208(11):571-4. PubMed ID: 26382622
[TBL] [Abstract][Full Text] [Related]
7. Measurable residual disease of canonical versus non-canonical DNMT3A, TET2, or ASXL1 mutations in AML at stem cell transplantation.
Jentzsch M; Grimm J; Bill M; Küpper J; Backhaus D; Brauer D; Schulz J; Franke GN; Vucinic V; Niederwieser D; Platzbecker U; Schwind S
Bone Marrow Transplant; 2021 Oct; 56(10):2610-2612. PubMed ID: 34267355
[No Abstract] [Full Text] [Related]
8. Blastic plasmacytoid dendritic cell neoplasm with t(2;8)(p12;q24).
Seiwell AP; Buckley K; Pettenati M; Grier DD
Pediatr Blood Cancer; 2020 Mar; 67(3):e28097. PubMed ID: 31782605
[No Abstract] [Full Text] [Related]
9. Cooperation of Dnmt3a R878H with Nras G12D promotes leukemogenesis in knock-in mice: a pilot study.
Shi X; Yang Y; Shang S; Wu S; Zhang W; Peng L; Huang T; Zhang R; Ren R; Mi J; Wang Y
BMC Cancer; 2019 Nov; 19(1):1072. PubMed ID: 31703632
[TBL] [Abstract][Full Text] [Related]
10. TET2 and DNMT3A mutations and exceptional response to 4'-thio-2'-deoxycytidine in human solid tumor models.
Yang SX; Hollingshead M; Rubinstein L; Nguyen D; Larenjeira ABA; Kinders RJ; Difilippantonio M; Doroshow JH
J Hematol Oncol; 2021 May; 14(1):83. PubMed ID: 34039392
[TBL] [Abstract][Full Text] [Related]
11. Mutant DNMT3A in acute myeloid leukemia: guilty of inducing genetic instability?
Zebisch A; Hoefler G; Quehenberger F; Wölfler A; Sill H
Leukemia; 2013 Aug; 27(8):1777-8. PubMed ID: 23417030
[No Abstract] [Full Text] [Related]
12. Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm.
Beer PA; Delhommeau F; LeCouédic JP; Dawson MA; Chen E; Bareford D; Kusec R; McMullin MF; Harrison CN; Vannucchi AM; Vainchenker W; Green AR
Blood; 2010 Apr; 115(14):2891-900. PubMed ID: 20008300
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous accumulation of plasmacytoid dendritic cells associated with acute myeloid leukemia: a rare condition distinct from blastic plasmacytoid dendritic cell neoplasm.
Dargent JL; Delannoy A; Pieron P; Husson B; Debecker C; Petrella T
J Cutan Pathol; 2011 Nov; 38(11):893-8. PubMed ID: 21883371
[TBL] [Abstract][Full Text] [Related]
14. Blastic plasmacytoid dendritic cell neoplasm arising from clonal hematopoiesis.
Suma S; Sakata-Yanagimoto M; Nguyen TB; Hattori K; Sato T; Noguchi M; Nannya Y; Ogawa S; Watanabe R; Fujimoto M; Nakamura N; Kusakabe M; Nishikii H; Kato T; Chiba S
Int J Hematol; 2018 Oct; 108(4):447-451. PubMed ID: 29705980
[TBL] [Abstract][Full Text] [Related]
15. Divergent Effects of Dnmt3a and Tet2 Mutations on Hematopoietic Progenitor Cell Fitness.
Ostrander EL; Kramer AC; Mallaney C; Celik H; Koh WK; Fairchild J; Haussler E; Zhang CRC; Challen GA
Stem Cell Reports; 2020 Apr; 14(4):551-560. PubMed ID: 32220332
[TBL] [Abstract][Full Text] [Related]
16. DNMT3A, TET2, and JAK2 mutations in polycythemia vera following long-term remission of secondary acute myeloid leukemia.
Jain P; Verstovsek S; Wang W; Loghavi S; Torres HA; Estrov Z; Patel KP; Pemmaraju N
Leuk Lymphoma; 2016 Aug; 57(8):1969-73. PubMed ID: 26700872
[No Abstract] [Full Text] [Related]
17. TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasm.
Jardin F; Ruminy P; Parmentier F; Troussard X; Vaida I; Stamatoullas A; Leprêtre S; Penther D; Duval AB; Picquenot JM; Courville P; Capiod JC; Tilly H; Bastard C; Marolleau JP
Br J Haematol; 2011 May; 153(3):413-6. PubMed ID: 21275969
[No Abstract] [Full Text] [Related]
18. Intracytoplasmic detection of TCL1--but not ILT7-by flow cytometry is useful for blastic plasmacytoid dendritic cell leukemia diagnosis.
Angelot-Delettre F; Biichle S; Ferrand C; Seilles E; Gaugler B; Harrivel V; Rosenthal-Allieri MA; Deconinck E; Saas P; Garnache-Ottou F
Cytometry A; 2012 Aug; 81(8):718-24. PubMed ID: 22674796
[TBL] [Abstract][Full Text] [Related]
19. TET2 and DNMT3A mutations in human T-cell lymphoma.
Couronné L; Bastard C; Bernard OA
N Engl J Med; 2012 Jan; 366(1):95-6. PubMed ID: 22216861
[No Abstract] [Full Text] [Related]
20. Concurrent STAT3, DNMT3A, and TET2 mutations in T-LGL leukemia with molecularly distinct clonal hematopoiesis of indeterminate potential.
Raess PW; Cascio MJ; Fan G; Press R; Druker BJ; Brewer D; Spurgeon SE
Am J Hematol; 2017 Jan; 92(1):E6-E8. PubMed ID: 27761930
[No Abstract] [Full Text] [Related]
[Next] [New Search]
